United Medical Systems, Inc. announces the acquisition of Mobile Biopsy, Inc., a Statesville, North Carolina based company, for an undisclosed cash amount. The acquisition of Mobile Biopsy will expand UMS' mobile stereotactic biopsy operations throughout the southeastern section of the country. Mobile Biopsy operates seven mobile stereotactic biopsy units serving approximately 50 customers throughout Alabama, Florida, Georgia, New Jersey, North Carolina, Pennsylvania, South Carolina, Tennessee, and Virginia.
United Medical Systems is an international leader in shared medical services providing mobile services to over 625 hospitals and medical centers in 32 states, Canada and South America. Over the past 12 years, UMS has performed over 125,000 breast biopsies. Other mobile services include extracorporeal shockwave lithotripsy and laser treatment of BPH.
Medical facilities taking advantage of UMS' mobile services have seen significant cost reductions by eliminating expensive equipment purchases and unnecessary maintenance programs, among other things. UMS continuously upgrades and provides the latest state-of-the-art equipment.
AI shows promise for predicting embryonic health without invasive testing